We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Two out of three?

23 April 2009 By Robert Cyran

Drug companies routinely bet billions on uncertain odds. Roche gambled by spending $47bn on Genentech just before the results of an important clinical trial were announced. It lost. Roche overpaid by billions, but it was a gamble worth taking.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)